Illumina Body Map 2
Name | miRBASE accession |
---|---|
hsa-miR-124-3p.1
|
MIMAT0000422 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_33793430 | 3.94 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr1_+_31885963 | 3.87 |
ENST00000373709.3
|
SERINC2
|
serine incorporator 2 |
chr5_+_75699040 | 3.20 |
ENST00000274364.6
|
IQGAP2
|
IQ motif containing GTPase activating protein 2 |
chr21_-_44846999 | 3.18 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
chr11_+_76494253 | 3.17 |
ENST00000333090.4
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
chr22_-_50746027 | 3.10 |
ENST00000425954.1
ENST00000449103.1 |
PLXNB2
|
plexin B2 |
chr17_+_6939362 | 3.05 |
ENST00000308027.6
|
SLC16A13
|
solute carrier family 16, member 13 |
chr15_+_91411810 | 2.93 |
ENST00000268171.3
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
chr10_+_89419370 | 2.85 |
ENST00000361175.4
ENST00000456849.1 |
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr9_+_137218362 | 2.84 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
chr1_+_154975110 | 2.84 |
ENST00000535420.1
ENST00000368426.3 |
ZBTB7B
|
zinc finger and BTB domain containing 7B |
chr19_+_54371114 | 2.83 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
chr2_-_216946500 | 2.81 |
ENST00000265322.7
|
PECR
|
peroxisomal trans-2-enoyl-CoA reductase |
chr11_+_120081475 | 2.80 |
ENST00000328965.4
|
OAF
|
OAF homolog (Drosophila) |
chr4_-_80994210 | 2.70 |
ENST00000403729.2
|
ANTXR2
|
anthrax toxin receptor 2 |
chr18_+_19749386 | 2.69 |
ENST00000269216.3
|
GATA6
|
GATA binding protein 6 |
chr17_-_202579 | 2.60 |
ENST00000577079.1
ENST00000331302.7 ENST00000536489.2 |
RPH3AL
|
rabphilin 3A-like (without C2 domains) |
chr7_-_27183263 | 2.59 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr19_-_10697895 | 2.55 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
chr1_-_154943212 | 2.51 |
ENST00000368445.5
ENST00000448116.2 ENST00000368449.4 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr12_+_53774423 | 2.46 |
ENST00000426431.2
|
SP1
|
Sp1 transcription factor |
chr9_+_22446814 | 2.44 |
ENST00000325870.2
|
DMRTA1
|
DMRT-like family A1 |
chr6_-_36515177 | 2.41 |
ENST00000229812.7
|
STK38
|
serine/threonine kinase 38 |
chr2_+_219264466 | 2.40 |
ENST00000273062.2
|
CTDSP1
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 |
chr15_-_55562582 | 2.38 |
ENST00000396307.2
|
RAB27A
|
RAB27A, member RAS oncogene family |
chr11_+_818902 | 2.37 |
ENST00000336615.4
|
PNPLA2
|
patatin-like phospholipase domain containing 2 |
chr11_+_60681346 | 2.33 |
ENST00000227525.3
|
TMEM109
|
transmembrane protein 109 |
chr2_-_122042770 | 2.29 |
ENST00000263707.5
|
TFCP2L1
|
transcription factor CP2-like 1 |
chr6_+_138725343 | 2.29 |
ENST00000607197.1
ENST00000367697.3 |
HEBP2
|
heme binding protein 2 |
chr4_-_129208940 | 2.24 |
ENST00000296425.5
|
PGRMC2
|
progesterone receptor membrane component 2 |
chr2_+_241508039 | 2.24 |
ENST00000270357.4
|
RNPEPL1
|
arginyl aminopeptidase (aminopeptidase B)-like 1 |
chr18_-_47340297 | 2.21 |
ENST00000586485.1
ENST00000587994.1 ENST00000586100.1 ENST00000285093.10 |
ACAA2
|
acetyl-CoA acyltransferase 2 |
chr8_-_134584152 | 2.19 |
ENST00000521180.1
ENST00000517668.1 ENST00000319914.5 |
ST3GAL1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
chr5_-_140998616 | 2.17 |
ENST00000389054.3
ENST00000398562.2 ENST00000389057.5 ENST00000398566.3 ENST00000398557.4 ENST00000253811.6 |
DIAPH1
|
diaphanous-related formin 1 |
chr17_-_1395954 | 2.16 |
ENST00000359786.5
|
MYO1C
|
myosin IC |
chr4_+_129730779 | 2.15 |
ENST00000226319.6
|
PHF17
|
jade family PHD finger 1 |
chr1_+_201979645 | 2.14 |
ENST00000367284.5
ENST00000367283.3 |
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
chr5_+_109025067 | 2.14 |
ENST00000261483.4
|
MAN2A1
|
mannosidase, alpha, class 2A, member 1 |
chr1_+_155108294 | 2.13 |
ENST00000303343.8
ENST00000368404.4 ENST00000368401.5 |
SLC50A1
|
solute carrier family 50 (sugar efflux transporter), member 1 |
chr17_-_41174424 | 2.09 |
ENST00000355653.3
|
VAT1
|
vesicle amine transport 1 |
chr11_+_75479763 | 2.08 |
ENST00000228027.7
|
DGAT2
|
diacylglycerol O-acyltransferase 2 |
chr9_-_110251836 | 2.08 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr20_+_361261 | 2.04 |
ENST00000217233.3
|
TRIB3
|
tribbles pseudokinase 3 |
chr11_+_111473108 | 2.04 |
ENST00000304987.3
|
SIK2
|
salt-inducible kinase 2 |
chr1_+_101361626 | 2.04 |
ENST00000370112.4
|
SLC30A7
|
solute carrier family 30 (zinc transporter), member 7 |
chr19_-_40791302 | 2.04 |
ENST00000392038.2
ENST00000578123.1 |
AKT2
|
v-akt murine thymoma viral oncogene homolog 2 |
chr12_+_1800179 | 2.03 |
ENST00000357103.4
|
ADIPOR2
|
adiponectin receptor 2 |
chr6_+_12012536 | 2.03 |
ENST00000379388.2
|
HIVEP1
|
human immunodeficiency virus type I enhancer binding protein 1 |
chr10_-_106098162 | 2.02 |
ENST00000337478.1
|
ITPRIP
|
inositol 1,4,5-trisphosphate receptor interacting protein |
chr10_+_72164135 | 2.01 |
ENST00000373218.4
|
EIF4EBP2
|
eukaryotic translation initiation factor 4E binding protein 2 |
chr12_+_121124599 | 2.01 |
ENST00000228506.3
|
MLEC
|
malectin |
chr1_-_236228403 | 2.00 |
ENST00000366595.3
|
NID1
|
nidogen 1 |
chr18_-_57027194 | 2.00 |
ENST00000251047.5
|
LMAN1
|
lectin, mannose-binding, 1 |
chr20_-_10654639 | 2.00 |
ENST00000254958.5
|
JAG1
|
jagged 1 |
chr18_+_29077990 | 1.99 |
ENST00000261590.8
|
DSG2
|
desmoglein 2 |
chr17_-_7297833 | 1.98 |
ENST00000571802.1
ENST00000576201.1 ENST00000573213.1 ENST00000324822.11 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr3_+_37903432 | 1.97 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr1_-_21671968 | 1.97 |
ENST00000415912.2
|
ECE1
|
endothelin converting enzyme 1 |
chr10_-_33246722 | 1.95 |
ENST00000437302.1
ENST00000396033.2 |
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
chr5_+_137801160 | 1.94 |
ENST00000239938.4
|
EGR1
|
early growth response 1 |
chr3_+_69812877 | 1.93 |
ENST00000457080.1
ENST00000328528.6 |
MITF
|
microphthalmia-associated transcription factor |
chr12_-_65146636 | 1.90 |
ENST00000418919.2
|
GNS
|
glucosamine (N-acetyl)-6-sulfatase |
chr1_-_201368707 | 1.88 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
chr1_+_182992545 | 1.87 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
chr10_-_33623564 | 1.86 |
ENST00000374875.1
ENST00000374822.4 |
NRP1
|
neuropilin 1 |
chr15_+_41523335 | 1.86 |
ENST00000334660.5
|
CHP1
|
calcineurin-like EF-hand protein 1 |
chr3_+_5229356 | 1.82 |
ENST00000256497.4
|
EDEM1
|
ER degradation enhancer, mannosidase alpha-like 1 |
chr2_-_161350305 | 1.81 |
ENST00000348849.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr14_+_70078303 | 1.80 |
ENST00000342745.4
|
KIAA0247
|
KIAA0247 |
chr2_-_208634287 | 1.80 |
ENST00000295417.3
|
FZD5
|
frizzled family receptor 5 |
chr10_+_17271266 | 1.79 |
ENST00000224237.5
|
VIM
|
vimentin |
chr11_+_832944 | 1.78 |
ENST00000322008.4
ENST00000397421.1 ENST00000529810.1 ENST00000526693.1 ENST00000525333.1 ENST00000524748.1 ENST00000527341.1 |
CD151
|
CD151 molecule (Raph blood group) |
chr11_-_86666427 | 1.77 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
chr5_-_101632153 | 1.77 |
ENST00000310954.6
|
SLCO4C1
|
solute carrier organic anion transporter family, member 4C1 |
chr12_-_15942309 | 1.76 |
ENST00000544064.1
ENST00000543523.1 ENST00000536793.1 |
EPS8
|
epidermal growth factor receptor pathway substrate 8 |
chr8_-_9008206 | 1.76 |
ENST00000310455.3
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B |
chr15_-_51058005 | 1.76 |
ENST00000261854.5
|
SPPL2A
|
signal peptide peptidase like 2A |
chr4_+_124320665 | 1.76 |
ENST00000394339.2
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr19_-_3761673 | 1.76 |
ENST00000316757.3
|
APBA3
|
amyloid beta (A4) precursor protein-binding, family A, member 3 |
chr1_-_6321035 | 1.75 |
ENST00000377893.2
|
GPR153
|
G protein-coupled receptor 153 |
chr6_-_75915757 | 1.75 |
ENST00000322507.8
|
COL12A1
|
collagen, type XII, alpha 1 |
chr8_-_141645645 | 1.74 |
ENST00000519980.1
ENST00000220592.5 |
AGO2
|
argonaute RISC catalytic component 2 |
chrX_+_68048803 | 1.72 |
ENST00000204961.4
|
EFNB1
|
ephrin-B1 |
chr10_-_60027642 | 1.71 |
ENST00000373935.3
|
IPMK
|
inositol polyphosphate multikinase |
chr16_+_69221028 | 1.71 |
ENST00000336278.4
|
SNTB2
|
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
chr8_+_74206829 | 1.70 |
ENST00000240285.5
|
RDH10
|
retinol dehydrogenase 10 (all-trans) |
chr5_-_100238956 | 1.68 |
ENST00000231461.5
|
ST8SIA4
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 |
chr1_-_234745234 | 1.68 |
ENST00000366610.3
ENST00000366609.3 |
IRF2BP2
|
interferon regulatory factor 2 binding protein 2 |
chr17_-_62207485 | 1.67 |
ENST00000433197.3
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1 |
chr12_+_113659234 | 1.67 |
ENST00000551096.1
ENST00000551099.1 ENST00000335509.6 ENST00000552897.1 ENST00000550785.1 ENST00000549279.1 |
TPCN1
|
two pore segment channel 1 |
chr1_+_64058939 | 1.66 |
ENST00000371084.3
|
PGM1
|
phosphoglucomutase 1 |
chr12_-_58240470 | 1.66 |
ENST00000548823.1
ENST00000398073.2 |
CTDSP2
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
chr16_-_4166186 | 1.65 |
ENST00000294016.3
|
ADCY9
|
adenylate cyclase 9 |
chr2_-_97405775 | 1.65 |
ENST00000264963.4
ENST00000537039.1 ENST00000377079.4 ENST00000426463.2 ENST00000534882.1 |
LMAN2L
|
lectin, mannose-binding 2-like |
chr14_+_21538429 | 1.63 |
ENST00000298694.4
ENST00000555038.1 |
ARHGEF40
|
Rho guanine nucleotide exchange factor (GEF) 40 |
chr14_+_103058948 | 1.63 |
ENST00000262241.6
|
RCOR1
|
REST corepressor 1 |
chr4_+_25235597 | 1.62 |
ENST00000264864.6
|
PI4K2B
|
phosphatidylinositol 4-kinase type 2 beta |
chr6_-_134639180 | 1.62 |
ENST00000367858.5
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr7_+_142960505 | 1.62 |
ENST00000409500.3
ENST00000443571.2 ENST00000358406.5 ENST00000479303.1 |
GSTK1
|
glutathione S-transferase kappa 1 |
chr3_-_133969437 | 1.61 |
ENST00000460933.1
ENST00000296084.4 |
RYK
|
receptor-like tyrosine kinase |
chrX_+_105937068 | 1.61 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr22_+_21996549 | 1.61 |
ENST00000248958.4
|
SDF2L1
|
stromal cell-derived factor 2-like 1 |
chr3_+_36421826 | 1.61 |
ENST00000273183.3
|
STAC
|
SH3 and cysteine rich domain |
chr1_-_150947343 | 1.60 |
ENST00000271688.6
ENST00000368954.5 |
CERS2
|
ceramide synthase 2 |
chr1_+_199996702 | 1.60 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr14_+_100705322 | 1.59 |
ENST00000262238.4
|
YY1
|
YY1 transcription factor |
chr2_-_71221942 | 1.59 |
ENST00000272438.4
|
TEX261
|
testis expressed 261 |
chr1_+_203274639 | 1.59 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
chr12_+_122516626 | 1.58 |
ENST00000319080.7
|
MLXIP
|
MLX interacting protein |
chr10_-_30024716 | 1.58 |
ENST00000375398.2
ENST00000375400.3 |
SVIL
|
supervillin |
chr4_-_122618095 | 1.57 |
ENST00000515017.1
ENST00000501272.2 ENST00000296511.5 |
ANXA5
|
annexin A5 |
chr21_+_35445827 | 1.55 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
chr2_+_28615669 | 1.55 |
ENST00000379619.1
ENST00000264716.4 |
FOSL2
|
FOS-like antigen 2 |
chr15_+_45315302 | 1.54 |
ENST00000267814.9
|
SORD
|
sorbitol dehydrogenase |
chr4_+_160188889 | 1.54 |
ENST00000264431.4
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr19_+_39138271 | 1.53 |
ENST00000252699.2
|
ACTN4
|
actinin, alpha 4 |
chr16_+_447209 | 1.52 |
ENST00000382940.4
ENST00000219479.2 |
NME4
|
NME/NM23 nucleoside diphosphate kinase 4 |
chr7_+_98972298 | 1.52 |
ENST00000252725.5
|
ARPC1B
|
actin related protein 2/3 complex, subunit 1B, 41kDa |
chr11_+_113930291 | 1.52 |
ENST00000335953.4
|
ZBTB16
|
zinc finger and BTB domain containing 16 |
chr11_+_64948665 | 1.52 |
ENST00000533820.1
|
CAPN1
|
calpain 1, (mu/I) large subunit |
chr18_+_29598335 | 1.52 |
ENST00000217740.3
|
RNF125
|
ring finger protein 125, E3 ubiquitin protein ligase |
chrX_+_41192595 | 1.51 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
chr11_+_94501497 | 1.51 |
ENST00000317829.8
ENST00000317837.9 ENST00000433060.2 |
AMOTL1
|
angiomotin like 1 |
chr6_+_7727030 | 1.50 |
ENST00000283147.6
|
BMP6
|
bone morphogenetic protein 6 |
chr14_-_21566731 | 1.50 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
chr12_+_52445191 | 1.50 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
chr22_-_26986045 | 1.50 |
ENST00000442495.1
ENST00000440953.1 ENST00000450022.1 ENST00000338754.4 |
TPST2
|
tyrosylprotein sulfotransferase 2 |
chr5_-_98262240 | 1.49 |
ENST00000284049.3
|
CHD1
|
chromodomain helicase DNA binding protein 1 |
chr11_+_12695944 | 1.49 |
ENST00000361905.4
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr12_-_7125770 | 1.49 |
ENST00000261407.4
|
LPCAT3
|
lysophosphatidylcholine acyltransferase 3 |
chr10_+_99473455 | 1.48 |
ENST00000285605.6
|
MARVELD1
|
MARVEL domain containing 1 |
chrX_+_66764375 | 1.47 |
ENST00000374690.3
|
AR
|
androgen receptor |
chr5_+_65440032 | 1.45 |
ENST00000334121.6
|
SREK1
|
splicing regulatory glutamine/lysine-rich protein 1 |
chr12_+_56915713 | 1.44 |
ENST00000262031.5
ENST00000552247.2 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr5_-_158526756 | 1.44 |
ENST00000313708.6
ENST00000517373.1 |
EBF1
|
early B-cell factor 1 |
chr17_+_1958388 | 1.44 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
chr22_+_50624323 | 1.44 |
ENST00000380909.4
ENST00000303434.4 |
TRABD
|
TraB domain containing |
chr6_+_143929307 | 1.43 |
ENST00000427704.2
ENST00000305766.6 |
PHACTR2
|
phosphatase and actin regulator 2 |
chr6_-_52441713 | 1.43 |
ENST00000182527.3
|
TRAM2
|
translocation associated membrane protein 2 |
chr15_-_65579177 | 1.42 |
ENST00000444347.2
ENST00000261888.6 |
PARP16
|
poly (ADP-ribose) polymerase family, member 16 |
chr14_-_77495007 | 1.42 |
ENST00000238647.3
|
IRF2BPL
|
interferon regulatory factor 2 binding protein-like |
chr9_-_33167308 | 1.41 |
ENST00000535206.1
ENST00000379731.4 |
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
chr1_-_39339777 | 1.41 |
ENST00000397572.2
|
MYCBP
|
MYC binding protein |
chr10_+_72575643 | 1.40 |
ENST00000373202.3
|
SGPL1
|
sphingosine-1-phosphate lyase 1 |
chr21_+_45875354 | 1.38 |
ENST00000291592.4
|
LRRC3
|
leucine rich repeat containing 3 |
chr11_+_32914579 | 1.38 |
ENST00000399302.2
|
QSER1
|
glutamine and serine rich 1 |
chr8_-_63998590 | 1.38 |
ENST00000260116.4
|
TTPA
|
tocopherol (alpha) transfer protein |
chr18_+_42260861 | 1.37 |
ENST00000282030.5
|
SETBP1
|
SET binding protein 1 |
chr6_+_35995488 | 1.37 |
ENST00000229795.3
|
MAPK14
|
mitogen-activated protein kinase 14 |
chr2_-_37899323 | 1.37 |
ENST00000295324.3
ENST00000457889.1 |
CDC42EP3
|
CDC42 effector protein (Rho GTPase binding) 3 |
chr1_+_223900034 | 1.36 |
ENST00000295006.5
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr5_-_95297678 | 1.36 |
ENST00000237853.4
|
ELL2
|
elongation factor, RNA polymerase II, 2 |
chr10_-_81965307 | 1.35 |
ENST00000537102.1
ENST00000372231.3 ENST00000438331.1 ENST00000422982.3 ENST00000360615.4 ENST00000265447.4 |
ANXA11
|
annexin A11 |
chr7_+_116165754 | 1.35 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr1_+_165796753 | 1.35 |
ENST00000367879.4
|
UCK2
|
uridine-cytidine kinase 2 |
chr1_+_203595903 | 1.35 |
ENST00000367218.3
ENST00000367219.3 ENST00000391954.2 |
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4 |
chr6_-_90121938 | 1.35 |
ENST00000369415.4
|
RRAGD
|
Ras-related GTP binding D |
chr4_+_152330390 | 1.34 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
chr13_+_28813645 | 1.34 |
ENST00000282391.5
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chrX_-_77150985 | 1.34 |
ENST00000358075.6
|
MAGT1
|
magnesium transporter 1 |
chr12_-_53625958 | 1.34 |
ENST00000327550.3
ENST00000546717.1 ENST00000425354.2 ENST00000394426.1 |
RARG
|
retinoic acid receptor, gamma |
chr9_+_2621798 | 1.34 |
ENST00000382100.3
|
VLDLR
|
very low density lipoprotein receptor |
chr2_+_109204909 | 1.33 |
ENST00000393310.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
chr1_+_2160134 | 1.33 |
ENST00000378536.4
|
SKI
|
v-ski avian sarcoma viral oncogene homolog |
chr2_-_165697920 | 1.33 |
ENST00000342193.4
ENST00000375458.2 |
COBLL1
|
cordon-bleu WH2 repeat protein-like 1 |
chr11_-_68609377 | 1.33 |
ENST00000265641.5
ENST00000376618.2 |
CPT1A
|
carnitine palmitoyltransferase 1A (liver) |
chr4_+_25657444 | 1.32 |
ENST00000504570.1
ENST00000382051.3 |
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 2 |
chr19_-_11450249 | 1.32 |
ENST00000222120.3
|
RAB3D
|
RAB3D, member RAS oncogene family |
chr11_+_125462690 | 1.32 |
ENST00000392708.4
ENST00000529196.1 ENST00000531491.1 |
STT3A
|
STT3A, subunit of the oligosaccharyltransferase complex (catalytic) |
chr6_+_158957431 | 1.32 |
ENST00000367090.3
|
TMEM181
|
transmembrane protein 181 |
chr6_+_125283566 | 1.30 |
ENST00000521654.2
|
RNF217
|
ring finger protein 217 |
chr11_-_125773085 | 1.30 |
ENST00000227474.3
ENST00000534158.1 ENST00000529801.1 |
PUS3
|
pseudouridylate synthase 3 |
chr11_+_20385327 | 1.30 |
ENST00000451739.2
ENST00000532505.1 |
HTATIP2
|
HIV-1 Tat interactive protein 2, 30kDa |
chr17_+_28705921 | 1.30 |
ENST00000225719.4
|
CPD
|
carboxypeptidase D |
chr1_-_179834311 | 1.30 |
ENST00000553856.1
|
IFRG15
|
Homo sapiens torsin A interacting protein 2 (TOR1AIP2), transcript variant 1, mRNA. |
chr2_-_43453734 | 1.29 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
chr7_+_17338239 | 1.28 |
ENST00000242057.4
|
AHR
|
aryl hydrocarbon receptor |
chr12_-_89919965 | 1.28 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
chr10_-_27443155 | 1.28 |
ENST00000427324.1
ENST00000326799.3 |
YME1L1
|
YME1-like 1 ATPase |
chr20_+_42086525 | 1.28 |
ENST00000244020.3
|
SRSF6
|
serine/arginine-rich splicing factor 6 |
chr5_+_56111361 | 1.28 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr1_+_15943995 | 1.28 |
ENST00000480945.1
|
DDI2
|
DNA-damage inducible 1 homolog 2 (S. cerevisiae) |
chr2_-_85829811 | 1.27 |
ENST00000306353.3
|
TMEM150A
|
transmembrane protein 150A |
chr12_-_118541743 | 1.27 |
ENST00000359236.5
|
VSIG10
|
V-set and immunoglobulin domain containing 10 |
chr5_+_49961727 | 1.27 |
ENST00000505697.2
ENST00000503750.2 ENST00000514342.2 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr18_-_19284724 | 1.26 |
ENST00000580981.1
ENST00000289119.2 |
ABHD3
|
abhydrolase domain containing 3 |
chr16_+_19125252 | 1.26 |
ENST00000566735.1
ENST00000381440.3 |
ITPRIPL2
|
inositol 1,4,5-trisphosphate receptor interacting protein-like 2 |
chr11_-_70507901 | 1.26 |
ENST00000449833.2
ENST00000357171.3 ENST00000449116.2 |
SHANK2
|
SH3 and multiple ankyrin repeat domains 2 |
chr6_-_109703663 | 1.25 |
ENST00000368961.5
|
CD164
|
CD164 molecule, sialomucin |
chr13_-_28194541 | 1.25 |
ENST00000316334.3
|
LNX2
|
ligand of numb-protein X 2 |
chr5_+_151151471 | 1.25 |
ENST00000394123.3
ENST00000543466.1 |
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1 |
chr19_-_12992274 | 1.24 |
ENST00000592506.1
ENST00000222219.3 |
DNASE2
|
deoxyribonuclease II, lysosomal |
chr6_-_53213780 | 1.24 |
ENST00000304434.6
ENST00000370918.4 |
ELOVL5
|
ELOVL fatty acid elongase 5 |
chr12_-_30848914 | 1.23 |
ENST00000256079.4
|
IPO8
|
importin 8 |
chrX_+_131157290 | 1.23 |
ENST00000394334.2
|
MST4
|
Serine/threonine-protein kinase MST4 |
chr4_+_87856129 | 1.23 |
ENST00000395146.4
ENST00000507468.1 |
AFF1
|
AF4/FMR2 family, member 1 |
chr7_-_106301405 | 1.22 |
ENST00000523505.1
|
CCDC71L
|
coiled-coil domain containing 71-like |
chr7_+_77166592 | 1.22 |
ENST00000248594.6
|
PTPN12
|
protein tyrosine phosphatase, non-receptor type 12 |
chr6_+_1312675 | 1.22 |
ENST00000296839.2
|
FOXQ1
|
forkhead box Q1 |
chr9_-_4741255 | 1.22 |
ENST00000381809.3
|
AK3
|
adenylate kinase 3 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 5.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.0 | 2.9 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
1.0 | 1.0 | GO:0060922 | cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.9 | 2.8 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.9 | 2.7 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.9 | 2.6 | GO:0060435 | bronchiole development(GO:0060435) |
0.7 | 2.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.7 | 2.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.7 | 2.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.6 | 1.9 | GO:0050720 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
0.6 | 3.9 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 3.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.6 | 1.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.6 | 2.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.6 | 2.8 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.5 | 1.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.5 | 1.5 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.5 | 1.5 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.5 | 1.5 | GO:0045720 | negative regulation of integrin biosynthetic process(GO:0045720) |
0.5 | 1.0 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.5 | 1.4 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.5 | 0.5 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.5 | 1.4 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.5 | 1.4 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.5 | 1.4 | GO:0033242 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.4 | 1.8 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.4 | 1.3 | GO:0009405 | pathogenesis(GO:0009405) |
0.4 | 2.1 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.4 | 1.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.4 | 1.6 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.4 | 2.0 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.4 | 2.8 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.4 | 1.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.4 | 2.8 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.4 | 1.9 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.4 | 1.9 | GO:0070885 | positive regulation of sodium:proton antiporter activity(GO:0032417) negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 2.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.4 | 1.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.4 | 2.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.4 | 2.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 2.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 2.4 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.3 | 1.4 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.3 | 1.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 1.0 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 0.9 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.3 | 0.9 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.3 | 1.9 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.3 | 2.5 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.3 | 1.2 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.3 | 2.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 1.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
0.3 | 1.5 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.9 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.3 | 3.9 | GO:0000050 | urea cycle(GO:0000050) |
0.3 | 1.8 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.3 | 1.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.3 | 3.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 1.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.3 | 1.2 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.3 | 1.2 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.3 | 2.0 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.3 | 0.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.3 | 2.3 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.3 | 3.7 | GO:0060056 | mammary gland involution(GO:0060056) |
0.3 | 1.7 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.3 | 0.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 2.0 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.3 | 1.4 | GO:0090212 | vitamin E metabolic process(GO:0042360) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.3 | 1.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.3 | 1.6 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.3 | 1.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.3 | 1.1 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.3 | 1.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 1.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.3 | 1.1 | GO:0043473 | pigmentation(GO:0043473) |
0.3 | 0.5 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.3 | 0.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.3 | 1.5 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 3.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.2 | 3.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 1.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 1.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.2 | 0.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.7 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.2 | 0.7 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.2 | 1.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.2 | 1.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 0.9 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.2 | 0.7 | GO:0034059 | response to anoxia(GO:0034059) |
0.2 | 0.9 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.2 | 0.7 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.2 | 2.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.4 | GO:0060490 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 0.8 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 0.8 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.2 | 1.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.2 | 1.0 | GO:0015862 | uridine transport(GO:0015862) |
0.2 | 2.7 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.2 | 0.6 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 1.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.2 | 3.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.2 | 2.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 0.6 | GO:0035261 | external genitalia morphogenesis(GO:0035261) canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
0.2 | 1.0 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 2.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.6 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.2 | 1.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 0.6 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.2 | 0.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.2 | 1.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.2 | 2.8 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.2 | 1.5 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.2 | 0.4 | GO:2000276 | negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
0.2 | 1.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.2 | 0.5 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.2 | 0.7 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.4 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.5 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.2 | 1.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 2.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.3 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.2 | 0.5 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.2 | 2.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 1.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 1.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 1.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.7 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.2 | 1.7 | GO:0015677 | copper ion import(GO:0015677) |
0.2 | 0.5 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) frontal suture morphogenesis(GO:0060364) |
0.2 | 0.7 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.2 | 2.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 1.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.2 | 2.5 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 1.0 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.2 | 0.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.9 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.2 | 0.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 1.7 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.2 | 0.6 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.2 | 0.5 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 0.8 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 1.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.2 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 2.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.2 | 0.3 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.2 | 1.1 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.7 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.4 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 1.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.4 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.1 | 1.0 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.7 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 1.3 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.8 | GO:0051604 | protein maturation(GO:0051604) |
0.1 | 1.1 | GO:0030578 | PML body organization(GO:0030578) |
0.1 | 1.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.1 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 1.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 1.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 2.6 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 2.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 2.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.6 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 1.5 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 1.6 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) renal sodium ion absorption(GO:0070294) |
0.1 | 1.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.4 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 1.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 3.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 1.4 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 1.2 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 0.3 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 1.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 1.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 1.1 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 1.2 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 1.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 1.0 | GO:0046836 | glycolipid transport(GO:0046836) |
0.1 | 0.8 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 1.5 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.1 | 0.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.1 | 0.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 1.0 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 1.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 3.9 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 1.2 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 1.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.6 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 1.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 1.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.2 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.1 | 0.5 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 0.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.1 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 1.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 2.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 4.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 1.1 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.1 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 0.5 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.1 | 1.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.3 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.1 | 0.6 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.1 | 0.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 1.7 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 1.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.7 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.1 | 1.0 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.9 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 2.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 1.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 1.9 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 1.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 1.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.3 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 1.2 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.7 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 0.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.1 | 1.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.1 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.1 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.6 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.4 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.1 | 4.0 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.9 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 1.9 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 1.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 1.4 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 1.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.2 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.8 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.4 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 0.4 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 0.5 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 1.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.1 | 0.4 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 1.5 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.1 | 0.4 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.1 | 0.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.5 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 0.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.1 | 0.5 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.1 | 1.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 2.4 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 0.2 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 1.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 1.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 1.0 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.2 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.1 | 0.9 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 2.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 2.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 1.5 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 1.4 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.1 | 2.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 2.4 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.1 | 0.1 | GO:1903352 | nitric oxide production involved in inflammatory response(GO:0002537) L-ornithine transmembrane transport(GO:1903352) L-arginine transmembrane transport(GO:1903400) |
0.1 | 7.4 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 0.2 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.0 | 1.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.2 | GO:0008050 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) Type I pneumocyte differentiation(GO:0060509) |
0.0 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 2.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 1.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 2.4 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.6 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.0 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 1.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.9 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.2 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.0 | 0.8 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.3 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 1.6 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 2.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 1.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.5 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
0.0 | 0.2 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.0 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.8 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 1.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.0 | 2.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 2.5 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) mRNA methylation(GO:0080009) |
0.0 | 1.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.6 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.7 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 1.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 1.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.5 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 2.9 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.0 | 0.6 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 1.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 1.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.7 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.7 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
0.0 | 0.6 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.8 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 0.5 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.4 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.0 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.9 | GO:0009607 | response to biotic stimulus(GO:0009607) |
0.0 | 0.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.9 | GO:0033280 | response to vitamin D(GO:0033280) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.6 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 1.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.8 | GO:0048026 | glycerophospholipid catabolic process(GO:0046475) positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 2.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 2.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 1.7 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 1.1 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.0 | 0.6 | GO:1900180 | regulation of protein localization to nucleus(GO:1900180) |
0.0 | 0.4 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.3 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.2 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.2 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
0.0 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 1.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 1.4 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.3 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.5 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.3 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.0 | 0.3 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
0.0 | 0.8 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 1.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.0 | 0.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.0 | 0.3 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.0 | 1.6 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.1 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.0 | 0.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 1.3 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.0 | 0.8 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.5 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.0 | 0.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.3 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.0 | 0.7 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 1.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.0 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.0 | 1.3 | GO:0030888 | regulation of B cell proliferation(GO:0030888) |
0.0 | 5.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.2 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.0 | 0.3 | GO:0048565 | digestive tract development(GO:0048565) |
0.0 | 0.1 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 1.1 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 1.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.7 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.4 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.3 | GO:0035358 | regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035358) positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.0 | 0.6 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.5 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.7 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.4 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 1.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0030421 | defecation(GO:0030421) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 2.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.1 | GO:0018032 | protein amidation(GO:0018032) |
0.0 | 0.9 | GO:0071594 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.0 | 0.9 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 1.0 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.8 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.1 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.2 | GO:0071218 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.0 | 0.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 1.3 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.0 | 0.7 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) |
0.0 | 1.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 1.0 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.5 | GO:0050832 | defense response to fungus(GO:0050832) |
0.0 | 0.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 1.0 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 1.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 1.4 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.6 | GO:0046467 | sphingolipid biosynthetic process(GO:0030148) membrane lipid biosynthetic process(GO:0046467) |
0.0 | 0.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.4 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 1.4 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.2 |